Adults with sickle cell disease (SCD) face a substantial risk of stroke, most often in their 30s and 40s,…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
A blood test measuring levels of the protein cystatin C may provide a more reliable way to monitor for…
Hormonal contraceptives — birth control medications that use lab-made versions of reproductive hormones — appear to be generally safe for…
Chronic pain among adolescents and young adults with sickle cell disease (SCD) is associated with more functional disability —…
A neurodevelopmental screening tool may identify toddlers and preschool children with sickle cell disease (SCD) who are at risk…
A high dose of pociredir, Fulcrum Therapeutics’ investigational oral therapy for sickle cell disease (SCD), was associated with…
Having a low household- or neighborhood-level socioeconomic status is not significantly associated with a higher risk of stroke in children…
Disc Medicine has launched a small clinical trial to test DISC-3405, its treatment candidate for reducing iron levels and…
New research shows that Black men with sickle cell disease (SCD) become biological parents at a lower rate than similarly…
Fentanyl may be a feasible, safe, and effective option when administered intranasally (into the nose), to manage acute moderate to…